目的提高局部进展期胰腺癌的治疗效果。
Objective To improve the therapeutic response and survival of locally advanced pancreatic cancer treated with radiochemotherapy.
乳腺癌术前化疗即新辅助化疗，使局部进展期乳腺癌的治疗取得了重大进展。
Nowadays, neoadjuvant chemotherapy, which is raised by clinic, made a big breakthrough in breast cancer partial treatment progression.
目的：评估在局部进展期直肠癌患者中联合贝伐单抗和标准放化疗的新辅助治疗有效性和安全性，并探索标志物反应。
Purpose To assess the safety and efficacy of neoadjuvant bevacizumab with standard chemoradiotherapy in locally advanced rectal cancer and explore biomarkers for response.
结论ET方案对局部进展期乳腺癌进行新辅助化疗，在肿瘤及淋巴结缩小（降期）效果方面，4周期组明显优于2周期组。
Conclusion Neo-adjuvant chemotherapy with ET regimen for 4 cycles were more effective than 2 cycles to down staging locally advanced breast cancer.
研究目的：局部进展期非小细胞肺癌，局部控制失败是死亡的重要原因，如果能在不增加治疗毒副作用前提下，提高局部控制率必然会提高疗效。
Objective:Local regional relapse is one of the most important factors which result in death for patients with local advanced non small cell lung cancer (NSCLC).
研究目的：局部进展期非小细胞肺癌，局部控制失败是死亡的重要原因，如果能在不增加治疗毒副作用前提下，提高局部控制率必然会提高疗效。
Objective:Local regional relapse is one of the most important factors which result in death for patients with local advanced non small cell lung cancer (NSCLC).
应用推荐